Atlas Trials

NEO-adjuvant Chemo-immunotherapy in Pancreatic Cancer

Clinical trial NCT06094140 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06094140
Sponsor
Australasian Gastro-Intestinal Trials Group
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2022-05-20
Primary completion
2024-06-30
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.